An observational study in Heart Failure, sponsored by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS. Completed at 1 site in Italy. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-03-16.
Sponsored by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS · Observational
Collection of data from patients with heart failure, both in the acute phase (data collection during hospital admission) and in the chronic phase (data collection during outpatient follow-up), optimization of the treatment of patients with heart failure, and implementation of a care model based on risk stratification.
The study is structured into two distinct phases: retrospective and prospective.
The retrospective phase aims to collect anamnestic, clinical, instrumental, and treatment data relating to patients diagnosed with heart failure, both at discharge (acute heart failure) and in the outpatient setting (chronic heart failure), referred to the Cardiovascular Department of ASST Papa Giovanni XXIII in Bergamo during the period from January 1, 2017 to May 31, 2020.
The same data relating to patients diagnosed with heart failure, both at discharge (acute heart failure) and in the outpatient setting (chronic heart failure), referred to the Cardiovascular Department of ASST Papa Giovanni XXIII will be collected prospectively over a three-year period (from June 1, 2020 to June 30, 2023). Each patient will be followed for one year from the index date of inclusion in the study.
5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.
This study's enrollment of 2,428 is above the median of 200 across 1,679 observational studies indexed under Heart Failure.
Browse Heart Failure studies →FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS is the lead sponsor of 20 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with diagnosis of heart failure.
Exclusion Criteria:
Heart failure free survival
Risk of adverse clinical events (mortality and morbidity) in the short to medium term.
Time frame: Follow up at 3 months, 6 months and 12 months
Improvement of 3C-HF prognostic score
Improvement of 3C-HF prognostic score in its predictive power for 90-day events (mortality and morbidity) by adding parameters from previously unexplored domains (e.g., biomarkers, frailty indices).
Time frame: Follow up at 3 months
3C-HF score for heart failure free survival
The prediction of the power of the 3C-HF score for long-term events (mortality and morbidity) over one year.
Time frame: Follow up at 12 months
Implement a transitional care model
The treatment of patients hospitalized for acute decompensation of heart failure and, at discharge, implement a transitional care model that takes into account the individual patient's clinical characteristics.
Time frame: Up to baseline
Prevent episodes of heart failure worsening.
Treatment of outpatients based on their individual risk profile for adverse clinical events, aiming to prevent episodes of heart failure worsening.
Time frame: Up to baseline
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS